The role of long non-coding RNA BCAR4 in human cancers

被引:9
|
作者
Yi, Qiong [1 ,2 ,3 ]
Liu, Zhongcheng [1 ,2 ,3 ]
Zhang, Kun [1 ,2 ,3 ]
Liu, Xuening [1 ,2 ,3 ]
Wang, Lifu [1 ,2 ,3 ]
Geng, Bin [1 ,2 ,3 ]
Xia, Yayi [1 ,2 ,3 ]
机构
[1] Lanzhou Univ, Hosp 2, Dept Orthopaed, Lanzhou 730000, Gansu, Peoples R China
[2] Orthopaed Key Lab Gansu Prov, Lanzhou 730000, Gansu, Peoples R China
[3] Orthopaed Clin Med Res Ctr Gansu Prov, Lanzhou 730000, Gansu, Peoples R China
基金
中国国家自然科学基金;
关键词
lncRNA; BCAR4; Cancer; Biomarker; Mechanism; BREAST-CANCER; CELL-PROLIFERATION; GASTRIC-CANCER; ANTIESTROGEN RESISTANCE; PROMOTES PROLIFERATION; TAMOXIFEN RESISTANCE; POOR-PROGNOSIS; LNCRNA BCAR4; STEM-CELLS; OSTEOSARCOMA;
D O I
10.1007/s13577-021-00556-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Long non-coding RNA (lncRNA) is a type of non-coding RNA with length of nucleotides > 200 bp. Increasing evidences show that lncRNA breast cancer antiestrogen resistance 4 (BCAR4) plays an important role in the occurrence and development of various human cancers. It is found that BCAR4 is highly expressed in diverse tumor tissues and cells, and the high expression of BCAR4 is usually associated with poor prognosis. BCAR4 is considered as an oncogene in human cancers. By competing endogenous RNA (ceRNA) mechanism and regulating different signaling pathways, BCAR4 participates in the proliferation, apoptosis, migration, invasion, epithelial-mesenchymal transition (EMT), metastasis and tumorigenesis of different cancers. In addition, overexpression of BCAR4 promotes drug resistance of tumor cells. Therefore, BCAR4 is a promising biomarker for cancer diagnosis and prognosis, and it is a potential target for cancer therapy. This paper reviews studies focusing on the relationship between BCAR4 and cancers in recent years and aims to summarize the effect and mechanism of BCAR4 in human cancers.
引用
收藏
页码:1301 / 1309
页数:9
相关论文
共 50 条
  • [1] The role of long non-coding RNA BCAR4 in human cancers
    Qiong Yi
    Zhongcheng Liu
    Kun Zhang
    Xuening Liu
    Lifu Wang
    Bin Geng
    Yayi Xia
    Human Cell, 2021, 34 : 1301 - 1309
  • [2] Long non-coding RNA BCAR4 promotes liver cancer progression by regulating proliferation, migration and invasion
    Wang, Aiyao
    Meng, Jun
    Liu, Hui
    Li, Chen
    Zhou, Zhiyong
    ONCOLOGY LETTERS, 2020, 20 (03) : 2779 - 2787
  • [3] Long non-coding RNA BCAR4 promotes chondrosarcoma cell proliferation and migration through activation of mTOR signaling pathway
    Shui, Xiaolong
    Zhou, Chengwei
    Lin, Wei
    Yu, Yang
    Feng, Yongzeng
    Kong, Jianzhong
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 242 (10) : 1044 - 1050
  • [4] The role of long non-coding RNA MIAT in cancers
    Da, Chao-ming
    Gong, Chao-Yang
    Nan, Wei
    Zhou, Kai-Sheng
    Wu, Zuo-Long
    Zhang, Hai-Hong
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [5] Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer
    Gong, Jianhua
    Zhang, Han
    He, Li
    Wang, Lixin
    Wang, Jipeng
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 241 (01): : 29 - 34
  • [6] NORAD, a critical long non-coding RNA in human cancers
    Soghli, Negin
    Yousefi, Tooba
    Abolghasemi, Maryam
    Qujeq, Durdi
    LIFE SCIENCES, 2021, 264
  • [7] Long Non-Coding RNA BCAR4 Binds to miR-644a and Targets TLX1 to Promote the Progression of Bladder Cancer
    Wang, Xiaojing
    He, Hongchao
    Rui, Wenbin
    Xie, Xin
    Wang, Dawei
    Zhu, Yu
    ONCOTARGETS AND THERAPY, 2020, 13 : 2483 - 2490
  • [8] Up-regulation of long non-coding RNA BCAR4 predicts a poor prognosis in patients with osteosarcoma, and promotes cell invasion and metastasis
    Ju, L.
    Zhou, Y. -M.
    Yang, G. -S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (21) : 4445 - 4451
  • [9] Long Non-Coding RNA in the Pathogenesis of Cancers
    Chi, Yujing
    Wang, Di
    Wang, Junpei
    Yu, Weidong
    Yang, Jichun
    CELLS, 2019, 8 (09)
  • [10] The Long Non-Coding RNA ANRIL in Cancers
    Sanchez, Aymeric
    Lhuillier, Julien
    Grosjean, Guillaume
    Ayadi, Lilia
    Maenner, Sylvain
    CANCERS, 2023, 15 (16)